"
Team:UT Dallas/Project
From 2011.igem.org
(Difference between revisions)
| Line 413: | Line 413: | ||
<li><a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Notebook</a></font></li> | <li><a href="https://2011.igem.org/Team:UT_Dallas/Notebook"><font size="3" face="verdana">Notebook</a></font></li> | ||
<li><a href="https://2011.igem.org/Team:UT_Dallas/HumanPractices"><font size="3" face="verdana">Human Practices</a></font></li> | <li><a href="https://2011.igem.org/Team:UT_Dallas/HumanPractices"><font size="3" face="verdana">Human Practices</a></font></li> | ||
| - | <li><a href="https://2011.igem.org/Team:UT_Dallas/ | + | <li><a href="https://2011.igem.org/Team:UT_Dallas/Safety"><font size="3" face="verdana">Safety</a></font></li> |
</ul> | </ul> | ||
| Line 433: | Line 433: | ||
<p> <font size="3" face="verdana">Tissue damage characterizes a range of medical conditions that can be particularly difficult to manage without restrictively risky or expensive intervention. The human body hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for synthetic bacterial systems. We aim to construct a probiotic solution that successfully interfaces with the immune system to facilitate localized tissue repair.</font></p><br></br> | <p> <font size="3" face="verdana">Tissue damage characterizes a range of medical conditions that can be particularly difficult to manage without restrictively risky or expensive intervention. The human body hosts a rich diversity of symbiotic microflora that provides a powerful engineering platform for synthetic bacterial systems. We aim to construct a probiotic solution that successfully interfaces with the immune system to facilitate localized tissue repair.</font></p><br></br> | ||
| - | |||
| - | |||
| - | |||
<br></br><br></br><br></br><br></br><br></br> | <br></br><br></br><br></br><br></br><br></br> | ||
Revision as of 01:58, 3 September 2011
UTDallas iGem
Subprojects
